This level of protection aligns with previous clinical trial data and underscores the vaccine’s potential to reduce hepatitis ...

Among these 87 patients with hepatitis E, nine had received a vaccine and 78 placebo, relating to a total vaccine efficiency of 88.5% (Figure 4). Among the subjects that completed three doses of ...

From a public health point of view, there are no specific strategies for prevention of hepatitis E virus infection. Exposures ...

Currently, more than 300 million people are diagnosed with hepatitis around the world, according to the World Hepatitis ...

Hepatitis can damage your liver for years without symptoms. Learn how these viruses spread—and what truly protects your liver ...

Use the purifier to isolate the hepatitis B antigen produced by the yeast cells. The vaccine, once administered, will stimulate the immune system to attack the antigen (i.e., the protein coat).

B, a new hepatitis vaccine, vs. standard hepatitis B vaccines as a booster in previously vaccinated individuals.